Novel Ulcerative Colitis Drug - Once-daily MMX Mesalazine Effective In Inducing Remission Of Mild-to-moderate Ulcerative Colitis

... Data presented at the 14th United European Gastroenterology Week (UEGW) congress shows that MMX mesalazine, a once-daily oral treatment for mild-to-moderate ulcerative colitis, is effective in inducing remission of the disease. Current 5-ASA treatments for ulcerative colitis need to be taken two or three times a day, which can lead to patient non-compliance and reduced drug efficacy. [click link for full article] ...